rss
J Neurol Neurosurg Psychiatry 2008;79:712-715 doi:10.1136/jnnp.2007.137026
  • Short report

Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer’s disease

  1. A Alberici1,
  2. L Bocchio2,
  3. C Geroldi3,
  4. R Zanardini2,
  5. C Bonomini3,
  6. G Bugari4,
  7. C Iacobello4,
  8. L Caimi4,
  9. M Gennarelli2,
  10. O Zanetti3,
  11. A Valerio5,6,
  12. E Nisoli6,
  13. B Borroni1,
  14. A Padovani1
  1. 1
    Department of Neurology, Brescia University, Italy
  2. 2
    Genetic, IRCCS San Giovanni di Dio-Fatebenefratelli, Brescia, Italy
  3. 3
    Alzheimer Unit, IRCCS San Giovanni di Dio-Fatebenefratelli, Brescia, Italy
  4. 4
    III Laboratory, Spedali Civili, Brescia, Italy
  5. 5
    Department of Biomedical Sciences and Biotechnologies, Brescia University, Italy
  6. 6
    Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, Chemotherapy and Medical Toxicology, Milan University, Italy
  1. Dr A Alberici, Department of Neurology, Brescia University, P.zzale Spedali Civili 1, 25100 Brescia, Italy; antoalberici{at}yahoo.it
  • Received 10 October 2007
  • Revised 13 December 2007
  • Accepted 13 January 2008
  • Published Online First 1 February 2008

Abstract

Frontotemporal lobar degeneration (FTLD) includes different heterogeneous conditions, mainly characterised by personality changes, along with cognitive deficits in language and executive functions. Movement disorders are variably represented. Behavioural disturbances constitute the core feature of FTLD, and eating disorders represent one of the most distinguishing symptoms between FTLD and Alzheimer’s disease (AD). The biochemical correlates of such dysfunctions remain to be defined. The adipocyte derived hormone leptin is known to play a foundamental role in food intake and energy balance. To understrand whether leptin could be involved in FTLD eating abnormalities, we measured serum leptin levels in 59 patients with FTLD compared with 25 with AD. Serum leptin levels in patients with FTLD were comparable with those in patients with AD. Nevertheless, females with FTLD showed significantly higher leptin levels compared with females with AD. No difference was found between FTDL and AD males or within the spectrum of patients with FTLD. Hyperphagic FTLD females showed higher circulating leptin levels in comparison with those without eating abnormalities; no differences were found between males with FTLD with respect to serum leptin and food intake disturbances. The present study showed a selective gender difference in leptin levels between females with FTLD and AD, which may suggest specific cognitive and behavioural networks need to be investigated.

Footnotes

  • Competing interests: None.

  • Ethics approval: The study was approved by the local ethics committees.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jnnp.2007.137026v1
    2. 79/6/712 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs